Compliance Fines Take a Bite Out of Pharma Companies’ Bottom Lines

The sharks are circling. On the heels of last fall’s announcement of a $14.7 million payment for FCPA violations in China by Bristol-Myers Squibb, compliance investigators are paying even closer attention to the Pharmaceuticals and Life Sciences...

2 Reasons why companies need to conduct risk assessments of their own compliance programs

As the aftermath of corporate corruption and ethics scandals continue to play out in news headlines and courtrooms, spurring a continued search for expert advice and best practices on mitigating compliance risk . So, when a former compliance expert at...

Monitoring Macro Trends: Everyone is Hot on the Environment

The environment has consistently been a hot topic, but at the end of 2015, it dominated headlines for weeks due to unusually warm temperatures in some places and extremely cold weather conditions in other parts of the United States. From tornadoes to...

What’s a PEP and Why Should You Care?

When it comes to finding your way around the regulatory landscape, the overabundant use of acronyms may make you feel like you need a translator by your side. FCPA, OAFC, BSA, PEP and others … keeping all of them straight could be a full-time job—if...

The Three Big Risks of Missing information

Making sound business decisions requires a significant amount of research and information gathering. Without knowing the history of a company or the market trends of the industry, your company can be exposed to liability concerns, reputational risks and...